Carcinogenesis, Vol. 22, No. 3, 367-374,
March 2001
© 2001 Oxford University Press
COMMENTARY |
Patterns of p53 G
T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
1 International Agency for Research on Cancer (WHO), 150 Cours Albert Thomas, 69372 Lyon cedex, France and
2 Department of Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA
It is unquestionable that the major cause of lung cancer is cigarette smoking. p53 mutations are common in lung cancers from smokers but less common in non-smokers. A large fraction of the p53 mutations in lung cancers are G
T transversions, a type of mutation that is infrequent in other tumors aside from hepatocellular carcinoma. Previous studies have indicated that there is a good correlation between GT transversion hotspots in lung cancers and sites of preferential formation of polycyclic aromatic hydrocarbon (PAH) adducts along the p53 gene. The origin of p53 mutations in lung cancer has been questioned by recent reports suggesting that there are no significant differences in p53 mutation spectra between smokers and non-smokers and between lung cancers and non-lung cancers [S.N.Rodin and A.S.Rodin (2000) Human lung cancer and p53: The interplay between mutagenesis and selection. Proc. Natl Acad. Sci. USA, 97, 12244–12249]. We have re-assessed these issues by using the latest update of the p53 mutation database of the International Agency for Research on Cancer (14 051 entries) as well as recent data from the primary literature on non-smokers. We come to the conclusion that the p53 mutation spectra are different between smokers and non-smokers and that this difference is highly statistically significant (GT transversions are 30 versus 10%; P < 0.0001, 
2 test). A similar difference is seen between lung cancers and non-lung cancers. At a number of mutational hotspots common to all cancers, a large fraction of the mutations are GT transversions in lung cancers but are almost exclusively GA transitions in non-lung cancers. Our data reinforce the notion that p53 mutations in lung cancers can be attributed to direct DNA damage from cigarette smoke carcinogens rather than to selection of pre-existing endogenous mutations.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Zhang, S. Wang, M. Wang, N. Tong, G. Fu, and Z. Zhang Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis Carcinogenesis, October 1, 2008; 29(10): 1973 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Riely, M. G. Kris, D. Rosenbaum, J. Marks, A. Li, D. A. Chitale, K. Nafa, E. R. Riedel, M. Hsu, W. Pao, et al. Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma Clin. Cancer Res., September 15, 2008; 14(18): 5731 - 5734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. vom Brocke, A. Krais, C. Whibley, M. C. Hollstein, and H. H. Schmeiser The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences Mutagenesis, September 2, 2008; (2008) gen049v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, Z. Zhang, H. Zhu, G. Fu, S. Wang, D. Wu, J. Zhou, Q. Wei, and Z. Zhang A Novel Functional Polymorphism C1797G in the MDM2 Promoter Is Associated with Risk of Bladder Cancer in a Chinese Population Clin. Cancer Res., June 1, 2008; 14(11): 3633 - 3640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.D. Lewis, B. Manshian, M.N. Routledge, G.B. Scott, and P.A. Burns Comparison of induced and cancer-associated mutational spectra using multivariate data analysis Carcinogenesis, April 1, 2008; 29(4): 772 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ruano-Ravina, R. Perez-Becerra, M. Fraga, K. T. Kelsey, and J. M. Barros-Dios Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure Ann. Onc., January 1, 2008; 19(1): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Hockley, V. M. Arlt, G. Jahnke, A. Hartwig, I. Giddings, and D. H. Phillips Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53 Carcinogenesis, January 1, 2008; 29(1): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Heist, W. Zhou, L. R. Chirieac, T. Cogan-Drew, G. Liu, L. Su, D. Neuberg, T. J. Lynch, J. C. Wain, and D. C. Christiani MDM2 Polymorphism, Survival, and Histology in Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., June 1, 2007; 25(16): 2243 - 2247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Herceg Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis, March 1, 2007; 22(2): 91 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Peltonen, J A Welsh, and K H Vahakangas Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene? Human and Experimental Toxicology, January 1, 2007; 26(1): 9 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Alexandrov, M. Rojas, and C. Rolando DNA Damage by Benzo(a)pyrene in Human Cells Is Increased by Cigarette Smoke and Decreased by a Filter Containing Rosemary Extract, Which Lowers Free Radicals Cancer Res., December 15, 2006; 66(24): 11938 - 11945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. v. Brocke, H. H. Schmeiser, M. Reinbold, and M. Hollstein MEF immortalization to investigate the ins and outs of mutagenesis Carcinogenesis, November 1, 2006; 27(11): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hagiwara, L. E. Mechanic, G. E. Trivers, H. L. Cawley, M. Taga, E. D. Bowman, K. Kumamoto, P. He, M. Bernard, S. Doja, et al. Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers Cancer Res., August 15, 2006; 66(16): 8309 - 8317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia and G. P. Pfeifer Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis Carcinogenesis, August 1, 2006; 27(8): 1526 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schollnberger, M. Manuguerra, H. Bijwaard, H. Boshuizen, H.P. Altenburg, S.M. Rispens, M.J.P. Brugmans, and P. Vineis Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model Carcinogenesis, July 1, 2006; 27(7): 1432 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-K. Toh, F. Gao, W.-T. Lim, S.-S. Leong, K.-W. Fong, S.-P. Yap, A. A.L. Hsu, P. Eng, H.-N. Koong, A. Thirugnanam, et al. Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity J. Clin. Oncol., May 20, 2006; 24(15): 2245 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Soussi, B. Asselain, D. Hamroun, S. Kato, C. Ishioka, M. Claustres, and C. Beroud Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection Clin. Cancer Res., January 1, 2006; 12(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Le Calvez, A. Mukeria, J. D. Hunt, O. Kelm, R. J. Hung, P. Taniere, P. Brennan, P. Boffetta, D. G. Zaridze, and P. Hainaut TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers Cancer Res., June 15, 2005; 65(12): 5076 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, K.-R. Muehlbauer, H. H. Schmeiser, M. Hergenhahn, D. Belharazem, and M. C. Hollstein p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung Tumors Cancer Res., April 1, 2005; 65(7): 2583 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, A. J. Marrogi, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, Y.-L. Zheng, S. Chanock, P. G. Shields, and C. C. Harris Polymorphisms in XPD and TP53 and mutation in human lung cancer Carcinogenesis, March 1, 2005; 26(3): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-K. Toh, E.-H. Wong, W.-T. Lim, S.-S. Leong, K.-W. Fong, J. Wee, and E.-H. Tan The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer: A Retrospective Analysis Chest, December 1, 2004; 126(6): 1750 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, A. Besaratinia, Z. Feng, M.-s. Tang, S. Amin, A. Luch, and G. P. Pfeifer DNA Damage, Repair, and Mutation Induction by (+)-Syn and (-)-Anti-Dibenzo[a,l]Pyrene-11,12-Diol-13,14-Epoxides in Mouse Cells Cancer Res., October 15, 2004; 64(20): 7321 - 7328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ono, H. Ikehata, V. P. Pithani, Y. Uehara, Y. Chen, Y. Kinouchi, T. Shimosegawa, and Y. Hosoi Spontaneous Mutations in Digestive Tract of Old Mice Show Tissue-Specific Patterns of Genomic Instability Cancer Res., October 1, 2004; 64(19): 6919 - 6923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Pleil, A. F. Vette, B. A. Johnson, and S. M. Rappaport Air levels of carcinogenic polycyclic aromatic hydrocarbons after the World Trade Center disaster PNAS, August 10, 2004; 101(32): 11685 - 11688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mazzone, T. Mekhail, and A. C. Arroliga Is Lung Cancer in the Nonsmoker a Different Disease? Chest, August 1, 2004; 126(2): 326 - 329. [Full Text] [PDF]
|
|
|
|
|
|
P. D. Lewis and J. M. Parry In silico p53 mutation hotspots in lung cancer Carcinogenesis, July 1, 2004; 25(7): 1099 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields Diet and alcohol consumption in relation to p53 mutations in breast tumors Carcinogenesis, June 1, 2004; 25(6): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Valadez and F. P. Guengerich S-(2-Chloroethyl)glutathione-generated p53 Mutation Spectra Are Influenced by Differential Repair Rates More than Sites of Initial DNA Damage J. Biol. Chem., April 2, 2004; 279(14): 13435 - 13446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vahakangas Ethical aspects of molecular epidemiology of cancer Carcinogenesis, April 1, 2004; 25(4): 465 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, M. Hergenhahn, H. H. Schmeiser, G. N. Wogan, A. Hong, and M. Hollstein Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene PNAS, March 2, 2004; 101(9): 2963 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, Z. Feng, and M.-s. Tang Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis Carcinogenesis, March 1, 2004; 25(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, et al. Tobacco and Cancer: Recent Epidemiological Evidence J Natl Cancer Inst, January 21, 2004; 96(2): 99 - 106. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Kris, R. B. Natale, R. S. Herbst, T. J. Lynch Jr, D. Prager, C. P. Belani, J. H. Schiller, K. Kelly, H. Spiridonidis, A. Sandler, et al. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer: A Randomized Trial JAMA, October 22, 2003; 290(16): 2149 - 2158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ahrendt, Y. Hu, M. Buta, M. P. McDermott, N. Benoit, S. C. Yang, L. Wu, and D. Sidransky p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study J Natl Cancer Inst, July 2, 2003; 95(13): 961 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamane, K. Shinmura, N. Sunaga, T. Saitoh, S. Yamaguchi, Y. Shinmura, K. Yoshimura, H. Murakami, Y. Nojima, T. Kohno, et al. Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo Carcinogenesis, June 1, 2003; 24(6): 1031 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, M. Costa, and M.-S. Tang Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells Carcinogenesis, April 1, 2003; 24(4): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Diergaarde, A. Vrieling, A. A. van Kraats, G. N.P. van Muijen, F. J. Kok, and E. Kampman Cigarette smoking and genetic alterations in sporadic colon carcinomas Carcinogenesis, March 1, 2003; 24(3): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Vineis, G Matullo, and M Manuguerra An evolutionary paradigm for carcinogenesis? J. Epidemiol. Community Health, February 1, 2003; 57(2): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, C.-S. Lee, and G. P. Pfeifer Simulated sunlight and benzo[a]pyrene diol epoxide induced mutagenesis in the human p53 gene evaluated by the yeast functional assay: lack of correspondence to tumor mutation spectra Carcinogenesis, January 1, 2003; 24(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, Z. Feng, J. Eveleigh, G. Iyer, J. Pan, S. Amin, F.-L. Chung, and M.-s. Tang The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma Carcinogenesis, November 1, 2002; 23(11): 1781 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J. Epidemiol. Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, F. A. Beland, and M.-s. Tang 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene Carcinogenesis, October 1, 2002; 23(10): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cairns Somatic stem cells and the kinetics of mutagenesis and carcinogenesis PNAS, August 6, 2002; 99(16): 10567 - 10570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia, S. E. Bates, and G. P. Pfeifer Mutational Signature of the Proximate Bladder Carcinogen N-Hydroxy-4-acetylaminobiphenyl: Inconsistency with the p53 Mutational Spectrum in Bladder Cancer Cancer Res., August 1, 2002; 62(15): 4331 - 4338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Cooper Smoking, lung cancers and their TP53 mutations Mutagenesis, July 1, 2002; 17(4): 279 - 280. [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia, L.M. Maas, E.M.C. Brouwer, E.J.C. Moonen, T.M.C.M. De Kok, G.J. Wesseling, S. Loft, J.C.S. Kleinjans, and F.J. Van Schooten A molecular dosimetry approach to assess human exposure to environmental tobacco smoke in pubs Carcinogenesis, July 1, 2002; 23(7): 1171 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hemminki, Y. Jiang, X. Ma, K. Yang, L. Egevad, and P. Lindblad Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors Carcinogenesis, May 1, 2002; 23(5): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, E. Komissarova, A. Pao, M.-C. Hung, G. M. Adair, and M.-s. Tang Transcription-coupled DNA Repair Is Genomic Context-dependent J. Biol. Chem., April 5, 2002; 277(15): 12777 - 12783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Haugen Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, February 1, 2002; 23(2): 227 - 229. [Full Text] [PDF]
|
|
|
|
|
|
M. Nacht, T. Dracheva, Y. Gao, T. Fujii, Y. Chen, A. Player, V. Akmaev, B. Cook, M. Dufault, M. Zhang, et al. Molecular characteristics of non-small cell lung cancer PNAS, December 18, 2001; 98(26): 15203 - 15208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rubin Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates Carcinogenesis, December 1, 2001; 22(12): 1903 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hainaut, M. Olivier, and G. P. Pfeifer TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database Mutagenesis, November 1, 2001; 16(6): 551 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Paschke Reply to the contribution of Hainaut, Olivier and Pfeifer (TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database) Mutagenesis, November 1, 2001; 16(6): 555 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers Cancer Res., October 1, 2001; 61(19): 7110 - 7117. [Abstract] [Full Text] [PDF]
|